EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Smolen, Josef S, Landewé, Robert, Breedveld, Ferdinand C, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile, Gorter, Simone, Knevel, Rachel, Nam, Jackie, Schoels, Monika, Aletaha, Daniel, Buch, Maya, Gossec, Laure, Huizinga, Tom, Bijlsma, Johannes W J W, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Gabay, Cem, Gomez-Reino, Juan, Kouloumas, Marios, Kvien, Tore K, Martin-Mola, Emilio, McInnes, Iain, Pavelka, Karel, van Riel, Piet, Scholte, Marieke, Scott, David L, Sokka, Tuulikki, Valesini, Guido, van Vollenhoven, Ronald, Winthrop, Kevin L, Wong, John, Zink, Angela, van der Heijde, Désirée
Formaat: Texto
Taal:English
Gepubliceerd in: BMJ Group 2010
Onderwerpen:
Recommendations
Online toegang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Gelijkaardige items